Search Login Register

valdecoxib (Bextra) Summary

Description: a COX-2 inhibitor; structure in first source

Also Known As: Bextra; Pfizer brand of valdecoxib; SC 65872; SC-65872; 4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide

Networked: 151 relevant articles (44 outcomes, 51 trials/studies) for this Drug

Key Diseases for which valdecoxib is Relevant

  1. Pain (Aches) : 21 outcomes 17 studies in 54 results
  2. Rheumatoid Arthritis : 9 outcomes 10 studies in 23 results
  3. Osteoarthritis : 7 outcomes 9 studies in 23 results
  4. Postoperative Pain : 7 outcomes 6 studies in 17 results
  5. Dysmenorrhea (Menstrual Pain) : 6 outcomes 2 studies in 11 results
Show All >>

Drugs Related to valdecoxib

  1. rofecoxib (Vioxx)
  2. Naproxen (Naprosyn)
  3. celecoxib (Celebrex)
  4. parecoxib
  5. Diclofenac (SR 38)
  6. Cyclooxygenase 2 (Cyclooxygenase-2)
  7. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
  8. Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
  9. Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
  10. valdecoxib (Bextra)
Show All >>

Therapies Related to valdecoxib

  1. Analgesia
  2. Laparoscopic Cholecystectomy
  3. Oral Surgery (Maxillofacial Surgery)
  4. Arthroplasty
  5. Combined Modality Therapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.